ALPS Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.49M | Sell |
3,825
-18
| -0.5% | -$7K | 0.01% | 417 |
|
|
2025
Q1 | $1.67M | Buy |
3,843
+40
| +1% | +$17.4K | 0.01% | 374 |
|
|
2024
Q4 | $1.4M | Sell |
3,803
-12
| -0.3% | -$4.43K | 0.01% | 404 |
|
|
2024
Q3 | $1.98M | Sell |
3,815
-4,257
| -53% | -$2.21M | 0.01% | 362 |
|
|
2024
Q2 | $4.37M | Hold |
8,072
| – | – | 0.03% | 242 |
|
|
2024
Q1 | $4.19M | Buy |
8,072
+104
| +1% | +$53.9K | 0.03% | 251 |
|
|
2023
Q4 | $3.76M | Buy |
7,968
+39
| +0.5% | +$18.4K | 0.03% | 254 |
|
|
2023
Q3 | $3.45M | Buy |
7,929
+6,700
| +545% | +$2.92M | 0.03% | 252 |
|
|
2023
Q2 | $546K | Sell |
1,229
-26
| -2% | -$11.6K | ﹤0.01% | 598 |
|
|
2023
Q1 | $577K | Sell |
1,255
-68
| -5% | -$31.3K | 0.01% | 565 |
|
|
2022
Q4 | $679K | Sell |
1,323
-73
| -5% | -$37.4K | 0.01% | 538 |
|
|
2022
Q3 | $634K | Buy |
+1,396
| New | +$634K | 0.01% | 553 |
|
|
2021
Q4 | – | Sell |
-1,348
| Closed | -$503K | – | 919 |
|
|
2021
Q3 | $503K | Sell |
1,348
-295
| -18% | -$110K | ﹤0.01% | 499 |
|
|
2021
Q2 | $627K | Sell |
1,643
-59
| -3% | -$22.5K | 0.01% | 488 |
|
|
2021
Q1 | $611K | Sell |
1,702
-1,420
| -45% | -$510K | 0.01% | 475 |
|
|
2020
Q4 | $1M | Sell |
3,122
-711
| -19% | -$228K | 0.01% | 389 |
|
|
2020
Q3 | $1.03M | Buy |
3,833
+2,988
| +354% | +$802K | 0.02% | 353 |
|
|
2020
Q2 | $222K | Sell |
845
-96
| -10% | -$25.2K | ﹤0.01% | 728 |
|
|
2020
Q1 | $214K | Buy |
+941
| New | +$214K | ﹤0.01% | 729 |
|
|
2017
Q1 | – | Sell |
-3,321
| Closed | -$477K | – | 767 |
|
|
2016
Q4 | $477K | Buy |
+3,321
| New | +$477K | ﹤0.01% | 442 |
|